Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

BVMF/MRCK34 stock hub

BVMF/MRCK34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/MRCK34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.3T

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/MRCK34

In the news

Latest news · BVMF/MRCK34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.9

P25 11.3P50 14.6P75 19.6

Trailing P/E28.9

P25 15.2P50 21.5P75 27.3

ROE18.9

P25 5.3P50 12.3P75 22.5

ROIC21.2

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/MRCK34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

229

Groups with data

Currency

USD

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	BR
Employees	74,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	BRL 1.6T
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	US58933Y1055
Last refreshed	2026-05-10
Market cap	BRL 1.3T
Price	BRL 68.04
Price currency	BRL
Rev Per Employee	4,636,399.59x
Sector	Healthcare
Sic	2834
Symbol	bvmf/MRCK34
Website	https://www.merck.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.46%
EV Earnings	33.47x
EV/EBIT	12.98x
EV/EBITDA	10.64x
EV/FCF	21.19x
EV/Sales	4.84x
FCF yield	5.47%
Forward P/E	17.9x
P/B ratio	5.62x
P/E ratio	28.9x
P/S ratio	3.93x
PE Ratio10 Y	54.31x
PE Ratio3 Y	99.8x
PE Ratio5 Y	67.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	37.3%
EBITDA Margin	44.88%
FCF margin	21.46%
Gross margin	76.73%
Gross Profit	BRL 263.2B
Gross Profit Growth	2.43%
Gross Profit Growth Q	2.18%
Gross Profit Growth3 Y	6.22%
Gross Profit Growth5 Y	10.9%
Net Income	BRL 46.6B
Net Income Growth	-48.75%
Net Income Growth3 Y	-11.82%
Net Income Growth5 Y	4.92%
Pretax Margin	17.68%
Profit Margin	13.59%
Profit Per Employee	BRL 629,884
ROA	12.58
Roa5y	11.18
ROCE	24.11
ROE	18.94
Roe5y	30.37
ROIC	21.18
Roic5y	22.36

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	13.6%
Cagr1y	23.34%
Cagr3y	-0.12%
Cagr5y	8.06%
Div CAGR10	10.84%
Div CAGR3	6.11%
Div CAGR5	5.06%
EPS Growth	-48.02
EPS Growth3 Y	-11.28
EPS Growth5 Y	5.25
FCF Growth	-17.16%
FCF Growth Q	149.74%
FCF Growth3 Y	7.82%
FCF Growth5 Y	16.21%
OCF Growth	-14.31%
OCF Growth Q	56.72%
OCF Growth10 Y	3.71%
OCF Growth3 Y	4.51%
OCF Growth5 Y	9.85%
Revenue Growth	2.89x
Revenue Growth Q	4.88x
Revenue Growth3 Y	4.36x
Revenue Growth5 Y	9.46x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.54
Assets	BRL 671.3B
Cash	BRL 29.7B
Current Assets	BRL 172.1B
Current Liabilities	BRL 132.4B
Debt	BRL 256.2B
Debt EBITDA	BRL 1.64
Debt Equity	BRL 1.07
Debt FCF	BRL 3.48
Equity	BRL 239.6B
Interest Coverage	16.11
Liabilities	BRL 431.7B
Long Term Assets	BRL 499.2B
Long Term Liabilities	BRL 299.3B
Net Cash	BRL -226.5B
Net Cash By Market Cap	BRL -16.81
Net Debt EBITDA	BRL 1.47
Net Debt Equity	BRL 0.95
Net Debt FCF	BRL 3.08
Tangible Book Value	BRL -7.6B
Tangible Book Value Per Share	BRL -3.06
WACC	4.85

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.3
Inventory Turnover	2.42
Net Working Capital	BRL 25.1B
Quick ratio	0.7
Working Capital	BRL 42.1B
Working Capital Turnover	BRL 37.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.79%
Dividend Growth	-2.94%
Dividend Growth Years	3%
Dividend per share	BRL 1.49
Dividend Years	17
Dividend Yield	2.19%
Ex Div Date	2026-03-13
Last Dividend	BRL 0.37
Payout Frequency	Quarterly
Payout Ratio	92.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	257.97%
1Y total return	23.32%
200-day SMA	66.29
3Y total return	-0.35%
50-day SMA	74.82
50-day SMA vs 200-day SMA	50over200
5Y total return	47.32%
All Time High	94
All Time High Change	-27.62%
All Time High Date	2024-07-01
All Time Low	8.83
All Time Low Change	670.55%
All Time Low Date	2011-12-28
ATR	2.27
Beta	0.2
Ch YTD	-6.96
High	69.09
High52	80.23
High52 Date	2026-02-24
High52ch	-15.19%
Low	68.04
Low52	51.6
Low52 Date	2025-05-15
Low52ch	31.86%
Ma50ch	-9.06%
Price vs 200-day SMA	2.64%
RSI	38.39
RSI Monthly	49.87
RSI Weekly	45.74
Sharpe ratio	0.72x
Sortino ratio	1.3
Total Return	3.99%
Tr YTD	-6.5
Tr1m	-11.27%
Tr1w	-3.53%
Tr3m	-13.07%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 128B
Operating Income Growth	0.5
Operating Income Growth Q	1.06
Operating Income Growth3 Y	7.38
Operating Income Growth5 Y	17.25
Operating margin	37.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,465,769,316%
Net Borrowing	67,806,131,600
Shares Insiders	0.05%
Shares Institutions	80%
Shares Qo Q	-0.64%
Shares Yo Y	-1.79%
Short Ratio	2.79

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 69.4B
Average Volume	3,684.85x
Bv Per Share	96.91
CAPEX	BRL -19.7B
Ch10y	191.3
Ch1m	-11.27
Ch1w	-3.53
Ch1y	20.43
Ch3m	-13.5
Ch3y	-6.32
Ch5y	32.5
Ch6m	18.64
Change	-5.3%
Change From Open	-1.52
Close	71.85
Days Gap	-3.84
Depreciation Amortization	24,492,372,800
Dollar Volume	159,009.5
Earnings Date	2026-04-30
EBIT	BRL 128B
EBITDA	BRL 154B
EPS	BRL 18.65
F Score	4
FCF	BRL 73.6B
FCF EV Yield	4.72x
Financing CF	4,444,649,700
Fiscal Year End	December
Founded	1,891
Goodwill	106,053,350,200
Graham Number	25.31612
Graham Upside	-62.79
Income Tax	BRL 14.1B
Investing CF	-117,188,510,400
Is Primary Listing	0
Last Earnings Date	2026-02-03
Last Report Date	2026-03-31
Last Split Date	2020-10-29
Last Split Type	Forward
Lynch Fair Value	BRL 11.77
Lynch Upside	-82.7
Ma150	69.69
Ma150ch	-2.36%
Ma20	72
Ma20ch	-5.5%
Net CF	-17,392,561,150
Open	69.09
P FCF Ratio	18.3
P OCF Ratio	14.44
Payment Date	2026-04-13
Position In Range	0
Ppne	124,982,848,600
Price Date	2026-05-08
Price EBITDA	BRL 8.75
Relative Volume	0.65x
Revenue	343,093,569,800x
SBC By Revenue	1.23x
Share Based Comp	4,225,547,250
Tax By Revenue	4.1x
Tax Rate	23.17%
Tr6m	19.93%
Volume	2,337
Z Score	3.62

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/MRCK34 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.2%

$1.49 annual per share

Payout ratio

+92.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.1%

3 consecutive years of growth

Total shareholder yield

+4.0%

Next ex-dividend date: 2026-03-13

Performance

BVMF/MRCK34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/MRCK34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+80.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVMF/MRCK34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.4

Neutral momentum band

Price vs 200-day MA

+2.6%

50/200-day relationship not available

Beta (5Y)

0.20

Less volatile than the market

Sharpe ratio

0.72

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/MRCK34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/MRCK34 stock rating?

bvmf/MRCK34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/MRCK34 analysis?

The full report lives at /stocks/bvmf/MRCK34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/MRCK34?

The latest report frames bvmf/MRCK34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/MRCK34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.